Stephen Betz Net Worth & Insider Trades
Stephen Betz - Chief Scientific Officer, Crinetics Pharmaceuticals, Inc
What is Stephen Betz's Net Worth?
The current estimated net worth of Crinetics Pharmaceuticals, Inc's Chief Scientific Officer, Stephen Betz, is estimated to be about $6.94M . Stephen Betz owns about 64,689 units of Crinetics Pharmaceuticals, Inc common stock. In the last 2 years at Crinetics Pharmaceuticals, Inc, Stephen Betz has sold an estimated value of $3.29M worth.
What is Stephen Betz's Past Insider Trading?
Stephen Betz's largest purchase order was 1,336 units , worth over $14.72K on September 6, 2022. Stephen Betz's largest sale order was 16,500 units , worth over $463.04K on November 9, 2021. In total, Stephen Betz has made about 33 transactions over 2 years of their time at Crinetics Pharmaceuticals, Inc. Stephen Betz usually trades in January, November and December, with the busiest year in 2022. The most recent transaction was a sale order of 3,126 units , worth over $61.24K on February 3, 2023.
Stephen Betz
Date Range: All Time
Ticker
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||
What is Stephen Betz's' Mailing Address?
- Mailing address is 10222 Barnes Canyon Road Building 2 San Diego CA 92121 CA
Crinetics Pharmaceuticals, Inc Executive Compensation
Name |
Year
|
Salary
|
Bonus
|
Stock Awards
|
Option Awards
|
Other Earnings Plans or Compensations
|
Other Compensation
|
Total
|
|---|---|---|---|---|---|---|---|---|
| R. Scott Struthers | 2020 | $543,550 | - | - | $3,006,000 | $276,782 | - | $3,826,332 |
| R. Scott Struthers | 2019 | $541,708 | - | - | $3,051,275 | $173,679 | - | $3,766,662 |
| Marc. S. Wilson | 2020 | $384,200 | - | - | $1,052,100 | $143,520 | - | $1,579,820 |
| Marc. S. Wilson | 2019 | $364,749 | - | - | $973,811 | $85,248 | - | $1,423,808 |
| Ajay Madan | 2020 | $412,967 | - | - | $1,052,100 | $154,560 | - | $1,619,627 |
| No matching records found | ||||||||
Source: https://www.sec.gov/Archives/edgar/data/1658247/000156459021022087/crnx-def14a_20210622.htm
What are Crinetics Pharmaceuticals, Inc's Past Insider Trades?
Crinetics Pharmaceuticals, Inc's most recent insider trade came on April 5, 2023 by Dana Pizzuti who sold 12,500 units worth $201.15K . In the last 5 years, insiders at Crinetics Pharmaceuticals, Inc have sold an estimated value of $45.31M and bought an estimated value of $63.19M worth of shares. Insider trading is most common in March, with the busiest year in 2022. The most active traders at the company are Stephen Betz, Chief Scientific Officer, Scott Richard Struthers, President & CEO, and Matthew Fust, Director .
Crinetics Pharmaceuticals, Inc. Insider Trades
Date Range: All Time
Insider Names
|
Type
|
Value
|
Price per Share
|
Shares
|
Filing Date
| ||
|---|---|---|---|---|---|---|---|
| No matching records found | |||||||